婴幼儿血管瘤临床治疗的研究现状

Research Status of Clinical Treatment of Infantile Hemangioma

婴幼儿血管瘤(Infantile Hemangioma, IH)是血管内皮细胞及其周围组织的良性增殖性疾病,是婴幼儿时期最常见的良性血管肿瘤。尽管IH是良性的,但仍有部分IH持续进展造成很多可能的不良后果,例如:溃疡、功能影响、毁容、合并其他疾病甚至可能危及生命,因此正确的评估及治疗对患者后期的转归尤为重要。IH的治疗选择在过去的十年发生了巨大的变化,越来越多的国内外学者提出了个体化及联合治疗方案。故本文探讨了IH的多种治疗方法及其转归情况。

Infantile hemangioma (IH) is a benign proliferative disease of vascular endothelial cells and sur-rounding tissues, which is the most common benign vascular tumor in infants. Although IH is be-nign, there are still some of it will continue to progress and cause plenty of possible adverse conse-quences, such as ulcer, functional impact, disfigurement, other complications and sometimes it could even be life-threatening. Therefore, appropriate assessment and treatment are particularly important to the prognosis of patients in the later stage. The choice of IH treatment has changed dramatically in the past decade, while an increasing number of domestic and foreign scholars pro-posed individualized and combined treatment protocols. Hence, this paper discusses various treatments of IH and the subsequent outcomes of patients in different therapeutic schedules.